September 10, 2019
Omeros Discovers New Cancer-Immunity Pathways Controlled by GPR174
— The Company’s GPR174 Inhibitors Enhance Anti-Tumor Activities of Adenosine Pathway Inhibitors by up to 25-Fold — SEATTLE–(BUSINESS WIRE)–Omeros Corporation…